Standardization of pathological investigations in the framework of experimental ASFV infections

► Review of the clinical and pathological presentations upon ASFV infection. ► Recommendations concerning the analysis of clinical as well as gross and microscopic pathological findings. ► Standardize the pathological report, the terminology employed and the evaluation of the severity of the lesions...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virus research 2013-04, Vol.173 (1), p.180-190
Hauptverfasser: Galindo-Cardiel, Iván, Ballester, María, Solanes, David, Nofrarías, Miquel, López-Soria, Sergio, Argilaguet, Jordi M., Lacasta, Anna, Accensi, Francesc, Rodríguez, Fernando, Segalés, Joaquim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► Review of the clinical and pathological presentations upon ASFV infection. ► Recommendations concerning the analysis of clinical as well as gross and microscopic pathological findings. ► Standardize the pathological report, the terminology employed and the evaluation of the severity of the lesions. ► Improve the inter-group data comparison between the ASFV research groups. African swine fever is still one of the major viral diseases of swine for which a commercial vaccine is lacking. For the design and development of such preventive products, researchers involved in African swine fever virus (ASFV) vaccinology need standardized challenge protocols and well characterized clinical, pathological and immunological responses of inbreed and outbreed pigs to different viral strains and vaccine-like products. The different approaches used should be assessed by immunologist, virologist and pathologist expertise. The main objectives of this guideline are to (1) briefly contextualize the clinical and pathological ASFV presentations focusing on points that are critical for pathogenesis, (2) provide recommendations concerning the analysis of clinical, gross and microscopic observations and (3) standardize the pathological report, the terminology employed and the evaluation of the severity of the lesions between the ASFV research groups for comparing inter-group data. The presented guidelines establish new approaches to integrate such relevant pathological data with virological and immunological testing, giving support to the global interpretation of the findings in the future experiments of ASFV-related vaccinology and immunology.
ISSN:0168-1702
1872-7492
DOI:10.1016/j.virusres.2012.12.018